USA - NYSE:RBOT - US92561V2088 - Common Stock
The current stock price of RBOT is 4.65 USD. In the past month the price decreased by -28.79%. In the past year, price decreased by -44.64%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.21 | 218.95B | ||
| ISRG | INTUITIVE SURGICAL INC | 62.58 | 193.16B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.51 | 146.46B | ||
| SYK | STRYKER CORP | 27.53 | 138.63B | ||
| MDT | MEDTRONIC PLC | 16.35 | 115.98B | ||
| IDXX | IDEXX LABORATORIES INC | 57.27 | 57.77B | ||
| BDX | BECTON DICKINSON AND CO | 12.55 | 51.32B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.74 | 49.40B | ||
| RMD | RESMED INC | 24.89 | 35.96B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.19 | 33.92B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.88 | 26.98B | ||
| DXCM | DEXCOM INC | 32.89 | 23.99B |
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
VICARIOUS SURGICAL INC-A
78 Fourth Avenue
Waltham MASSACHUSETTS US
CEO: David Chu
Employees: 121
Phone: 16178681700
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Waltham, Massachusetts and currently employs 123 full-time employees. The company went IPO on 2020-09-04. The firm is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
The current stock price of RBOT is 4.65 USD. The price decreased by -6.25% in the last trading session.
RBOT does not pay a dividend.
RBOT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
9 analysts have analysed RBOT and the average price target is 10.2 USD. This implies a price increase of 119.35% is expected in the next year compared to the current price of 4.65.
VICARIOUS SURGICAL INC-A (RBOT) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
VICARIOUS SURGICAL INC-A (RBOT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-10.09).
ChartMill assigns a fundamental rating of 2 / 10 to RBOT. RBOT has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months RBOT reported a non-GAAP Earnings per Share(EPS) of -10.09. The EPS increased by 2.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -145.82% | ||
| ROE | -258.54% | ||
| Debt/Equity | 0 |
9 analysts have analysed RBOT and the average price target is 10.2 USD. This implies a price increase of 119.35% is expected in the next year compared to the current price of 4.65.